EGFR mutation-positive caused lack of TILs, impaired the antigen specific signal, made tumor cells unrecognizable to T cells, reduced programmed death receptor ligand-1 (PD-L1) expression, lower tumor mutation burden (TMB) (34–36). The gene discussed is CD274; the disease is neoplasm.